Mast cell tumours (MCTs) are common tumours in dogs. They mainly affect the skin, although they can affect other tissues and organs. In recent years, there have been significant advances in predicting skin MCT behaviour and treatment, including the licensing of two tyrosine kinase inhibitors for the treatment of this condition. This article focuses on skin (cutaneous and subcutaneous) MCTs. It summarises current understanding of MCT behaviour, prognosis and treatment, with a particular focus on treatment decision-making.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.